| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 611,000 | 651,000 | 674,000 | 709,000 | | Cost of Revenue | 137,000 | 148,000 | 151,000 | 147,000 | | | Gross Profit | 474,000 | 503,000 | 523,000 | 562,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 271,000 | 270,000 | 321,000 | 289,000 | | Non Recurring |
-
|
-
|
-
| 225,000 | | Others | 17,000 | 17,000 | 17,000 | 19,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 186,000 | 216,000 | 185,000 | 29,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (9,000) | (396,000) |
-
| | Earnings Before Interest And Taxes | (402,000) | 612,000 | (211,000) | 29,000 | | Interest Expense | (151,000) | (3,000) | 154,000 | 156,000 | | Income Before Tax | (251,000) | 615,000 | (365,000) | (127,000) | | Income Tax Expense | 53,000 | 68,000 | (122,000) | (50,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 101,000 | 142,000 | (243,000) | (77,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 101,000 | 142,000 | (243,000) | (77,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $101,000 | $142,000 | ($243,000) | ($77,000) |
|
0.51% Nasdaq 
0.0009 (20.45%) 
Income Statement
